Business Context and Reporting Period
Dune Acquisition Corporation II (the "Company"), a Cayman Islands-based special purpose acquisition company (SPAC), filed this Form 8-K on May 14, 2025, to report events occurring on May 8, 2025. The Company is an emerging growth company with securities trading on The Nasdaq Stock Market LLC under the symbols IPODU (Units), IPOD (Class A ordinary shares), and IPODW (Warrants).
Key Financial Metrics
- Initial Public Offering (IPO): Sold 14,375,000 Units at $10.00 per Unit, generating gross proceeds of $143,750,000. This included the full exercise of the underwriters' over-allotment option for 1,875,000 additional Units.
- Private Placement: Sold 2,000,000 Private Placement Warrants to Dune Acquisition Holdings II LLC at $1.00 per warrant, generating gross proceeds of $2,000,000.
- Total Gross Proceeds: $145,750,000 ($143,750,000 from IPO + $2,000,000 from Private Placement).
- Trust Account Funding: $144,109,375 was deposited into a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. This amount includes $142,109,375 from the IPO (incorporating up to $5,750,000 of deferred underwriting discounts) and the full $2,000,000 from the Private Placement.
- Warrant Terms: Each whole warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share.
Material Changes
This filing represents the consummation of the Company's IPO and the simultaneous private placement. As this is the initial public offering, there are no prior comparable periods for revenue, profit, or cash flow comparisons. The primary material change is the transition from a pre-IPO entity to a public company with significant cash liquidity held in trust.
Outlook, Risks, and Management Commentary
The filing confirms the successful completion of the capital raise required to fund the Company's search for a target business. An audited balance sheet as of May 8, 2025, reflecting these proceeds, is included as Exhibit 99.1. The filing does not provide specific guidance on the timeline for a business combination, nor does it detail specific risks beyond standard SPAC structures (e.g., warrant redemption, trust account maintenance). The deferred underwriting discount of up to $5,750,000 remains contingent on the consummation of a business combination.
Investor Verification Checklist
- Verify the final amount of the deferred underwriting discount ($5,750,000) and the conditions for its payment.
- Review the Audited Balance Sheet (Exhibit 99.1) to confirm the exact cash balance and any immediate transaction costs deducted from the trust.
- Confirm the specific terms regarding the redemption of warrants and the trust account distribution in the event of a liquidation or failed business combination.
- Monitor future filings for the identification of a target business and the proposed terms of the initial business combination.